Dogwood Therapeutics, Inc.
Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.
DWTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 44 MILTON AVENUE, 30009 ALPHARETTA
- Website:
- https://dwtx.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Dogwood Therapeutics, Inc. is a development-stage biotechnology company focused on advancing novel therapeutics for pain and neuropathy. The company targets significant unmet medical needs in conditions such as chemotherapy-induced neuropathic pain (CINP), chemotherapy-induced peripheral neuropathy (CIPN), and fibromyalgia. Its lead candidate, Halneuron®, is a non-opioid pain management treatment being evaluated in Phase 2B clinical trials. Halneuron® is designed to provide long-duration pain relief with minimal side effects and without evidence of addiction, withdrawal symptoms, or tolerance buildup. The company's pipeline also includes SP16, a therapeutic candidate in Phase 1B development for cancer-related pain.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Dogwood Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dogwood Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dogwood Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
